RNAi for Therapeutic Applications: Technology and Market 2014-2024

RNAi for Therapeutic Applications:RNAi for Therapeutic Applications: Technology and Market 2014-2024 PR Newswire LONDON, February 20, 2014 Potential of RNAi therapies - new analysis showing R&D, trends, and revenue prospects Where are RNA interference based medicines going? For those treatments you can get new sales predictions and explore developments. You unlock that emerging medical industry. And you assess its results, trends, technologies, potentials, and opportunities. Visiongain's new report forecasts those revenues to 2024 at overall world market, product, and national level. Discover now what's happening. You stay ahead in data, then, helping your influence. Hear about potential gains for companies pioneering those drugs. Forecasts to 2024 and other analyses predict and explain the RNAi- based drug market Why miss data you need? Why struggle to find it? Instead our report gives you revenue forecasts to 2024, also with historical data, growth rates, and market shares. Also you investigate research and development, assessing its potential. The study also gives 59 tables, 26 charts, and interviews with two companies. Prospects for that technology - analyses showing where the money lies The new report shows the lucrative opportunities for ribonucleic acid interference (RNAi) technologies. And you discover forecasting for both optimistic and conservative scenarios. Those analyses predict how much money the pharma industry can earn.